These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36499438)

  • 1. Comparison of Body Composition, Muscle Strength and Cardiometabolic Profile in Children with Prader-Willi Syndrome and Non-Alcoholic Fatty Liver Disease: A Pilot Study.
    Mager DR; MacDonald K; Duke RL; Avedzi HM; Deehan EC; Yap J; Siminoski K; Haqq AM
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Alcoholic Fatty Liver Disease (NAFLD) in children and adolescents with Prader-Willi Syndrome (PWS).
    Fintini D; Inzaghi E; Colajacomo M; Bocchini S; Grugni G; Brufani C; Cappa M; Nobili V; Cianfarani S; Crinò A
    Pediatr Obes; 2016 Jun; 11(3):235-8. PubMed ID: 26132376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiopoietin-like 8 (ANGPTL8) as a potential predictor of NAFLD in paediatric patients with Prader-Willi Syndrome.
    Mele C; Crinò A; Fintini D; Mai S; Convertino A; Bocchini S; Di Paolo P; Grugni G; Aimaretti G; Scacchi M; Marzullo P
    J Endocrinol Invest; 2021 Jul; 44(7):1447-1456. PubMed ID: 33067796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between metabolic syndrome, cytokines and physical activity in obese youth with and without Prader-Willi syndrome.
    McAlister KL; Fisher KL; Dumont-Driscoll MC; Rubin DA
    J Pediatr Endocrinol Metab; 2018 Aug; 31(8):837-845. PubMed ID: 29975666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is non-alcoholic fatty liver disease less frequent among women with Prader-Willi syndrome?
    Bedogni G; Grugni G; Nobili V; Agosti F; Saezza A; Sartorio A
    Obes Facts; 2014; 7(1):71-6. PubMed ID: 24577228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of magnetic resonance imaging to characterize abnormal body composition phenotypes in youth with Prader-Willi syndrome.
    Orsso CE; Mackenzie M; Alberga AS; Sharma AM; Richer L; Rubin DA; Prado CM; Haqq AM
    Metabolism; 2017 Apr; 69():67-75. PubMed ID: 28285653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peculiar body composition in patients with Prader-Labhart-Willi syndrome.
    Brambilla P; Bosio L; Manzoni P; Pietrobelli A; Beccaria L; Chiumello G
    Am J Clin Nutr; 1997 May; 65(5):1369-74. PubMed ID: 9129464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle characteristics and motor performance after 2-year growth hormone treatment in adults with prader-willi syndrome.
    Lafortuna CL; Minocci A; Capodaglio P; Gondoni LA; Sartorio A; Vismara L; Rizzo G; Grugni G
    J Clin Endocrinol Metab; 2014 May; 99(5):1816-24. PubMed ID: 24471571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome.
    Carrel AL; Myers SE; Whitman BY; Eickhoff J; Allen DB
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1131-6. PubMed ID: 20061431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fat-Free Mass Is Better Related to Serum Uric Acid Than Metabolic Homeostasis in Prader-Willi Syndrome.
    Marzullo P; Mele C; Minocci A; Mai S; Scacchi M; Sartorio A; Aimaretti G; Grugni G
    Nutrients; 2020 Aug; 12(9):. PubMed ID: 32854398
    [No Abstract]   [Full Text] [Related]  

  • 12. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained benefits of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent.
    Carrel AL; Myers SE; Whitman BY; Allen DB
    J Pediatr Endocrinol Metab; 2001; 14(8):1097-105. PubMed ID: 11592566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome in adult patients with Prader-Willi syndrome.
    Grugni G; Crinò A; Bedogni G; Cappa M; Sartorio A; Corrias A; Di Candia S; Gargantini L; Iughetti L; Pagano C; Ragusa L; Salvatoni A; Spera S; Vettor R; Chiumello G; Brambilla P
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1134-40. PubMed ID: 23220075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strength characterization of knee flexor and extensor muscles in Prader-Willi and obese patients.
    Capodaglio P; Vismara L; Menegoni F; Baccalaro G; Galli M; Grugni G
    BMC Musculoskelet Disord; 2009 May; 10():47. PubMed ID: 19419559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD).
    Mager DR; Iñiguez IR; Gilmour S; Yap J
    JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):73-84. PubMed ID: 23976771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study.
    Carrel AL; Myers SE; Whitman BY; Allen DB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1581-5. PubMed ID: 11932286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth Hormone Treatment for Adults With Prader-Willi Syndrome: A Meta-Analysis.
    Rosenberg AGW; Passone CGB; Pellikaan K; Damiani D; van der Lely AJ; Polak M; Bernardo WM; de Graaff LCG
    J Clin Endocrinol Metab; 2021 Sep; 106(10):3068-3091. PubMed ID: 34105729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body composition and fatness patterns in Prader-Willi syndrome: comparison with simple obesity.
    Theodoro MF; Talebizadeh Z; Butler MG
    Obesity (Silver Spring); 2006 Oct; 14(10):1685-90. PubMed ID: 17062796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor (AR) gene CAG trinucleotide repeat length associated with body composition measures in non-syndromic obese, non-obese and Prader-Willi syndrome individuals.
    Butler MG; Manzardo AM
    J Assist Reprod Genet; 2015 Jun; 32(6):909-15. PubMed ID: 25925349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.